MDGL

$499.40-0.06%website ↗⬇ financials (.py)

MADRIGAL PHARMACEUTICALS, INC.

Market Cap

$11.5B

Live price × shares (2026-09-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-1.08

60mo monthly vs SPY

P/E (TTM)

N/M

Price / TTM net income

P/S (TTM)

9.0

Price / TTM revenue

P/B

22.0

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →

Velocity Score

6.83x

Sell Rate (90d)

163.86/mo

Sell Baseline

59.58/mo

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-11	2026-09-11	Sibold William John	Director & President and CEO	Sale	5,221	$542.39	$2.83M	197.7K	View
2026-09-09	2026-09-11	Sibold William John	Director & President and CEO	Sale	6,362	$535.59	$3.41M	203.0K	View
2026-08-17	2026-08-20	Kelley Shannon T	General Counsel	Sale	664	$514.97	$342K	11.5K	View
2026-07-20	2026-07-20	Sibold William John	Director & President and CEO	Sale	2,500	$547.30	$1.37M	209.3K	View
2026-06-01	2026-06-01	Soergel David	Chief Medical Officer	Sale	1,042	$495.74	$517K	10.0K	View

1–5 of 14

1 / 3

MDGL

Signals

Factor Profile

Reporting Insiders

Recent News

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Factor Profile

Date	Insider	Type	Shares	Value
2026-09-11	Sibold William John	S	1,539	$837,252.94
2026-09-11	Sibold William John	S	120	$65,565.2
2026-09-11	Sibold William John	S	60	$31,985.48
2026-09-11	Sibold William John	S	106	$56,610.68
2026-09-11	Sibold William John	S	218	$116,835.68